Skip to content

NKTR — Nektar Therapeutics Institutional Holders · Q3 2026

Who owns Nektar Therapeutics (NKTR)? 280 institutions reported holding $2.35B in SEC 13F filings for Q3 2026 (period ended 2026-09-30). Largest holders: FMR LLC ($310.1M), Two Seas Capital LP ($202.6M), BlackRock, Inc. ($173.9M).

RankInstitutionValueSharesChange
1FMR LLC$310.1M5.1MAdded
2Two Seas Capital LP$202.6M3.3MAdded
3BlackRock, Inc.$173.9M2.9MTrimmed
4VANGUARD GROUP INC$130.5M2.2MAdded
5BVF INC/IL$129.2M2.1MTrimmed
6STATE STREET CORP$107.3M1.8MAdded
7SUSQUEHANNA INTERNATIONAL GROUP, LLP$94.2M1.6MAdded
8TWO SIGMA INVESTMENTS, LP$73.2M1.2MAdded
9GEODE CAPITAL MANAGEMENT, LLC$54.0M891,927Added
10MORGAN STANLEY$50.3M830,210Trimmed
11Prosight Management, LP$47.5M785,000Trimmed
12ARMISTICE CAPITAL, LLC$42.4M700,000Trimmed
13GOLDMAN SACHS GROUP INC$37.6M621,249Added
14BANK OF AMERICA CORP /DE/$33.0M544,805Added
15Vestal Point Capital, LP$30.9M510,000Trimmed
16GILDER GAGNON HOWE & CO LLC$30.2M499,603Trimmed
17Woodline Partners LP$28.5M471,402Added
18BRAIDWELL LP$26.9M443,591Trimmed
19CITADEL ADVISORS LLC$25.6M422,203Trimmed
20Creek Drive Management Group LLC$25.2M417,000Added
21ORBIMED ADVISORS LLC$23.3M384,520Trimmed
22EMERALD ADVISERS, LLC$23.0M380,029Trimmed
23Sofinnova Investments, Inc.$22.3M367,963Trimmed
24MILLENNIUM MANAGEMENT LLC$21.4M353,632Trimmed
25IMC-Chicago, LLC$20.5M337,890Added

Source: SEC Form 13F filings · as of 2026-09-30